Cash position, page-12

While I am very open to the possibility of bankruptcy (have been since 2015), I will be very surprised they wont nab another Amgen-like convertible note. Just looking at Big Pharma partnership webpages (Roche, Eli Lilli, etc), they are all seeking partnerships in novel drug delivery devices for biologics. In fact, Eli Lilly now has a recent ex-employee of Unilife heading their connected drug delivery unit. Unless these guys have already-signed confidential partnerships with West or Insulet or Enable, these big pharma do not have novel delivery solutions for biologics other than auto-injectors and PFS. This contradicts what they say on their partnership webpages and they are quite frankly leaving their run a little late. I see the demand out there, which is why I will be surprised if our company goes under if it is a result of a new partnership that wasnt consummated.....